Does PEMBROLIZUMAB Cause Lung disorder? 461 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 461 reports of Lung disorder have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.6% of all adverse event reports for PEMBROLIZUMAB.
461
Reports of Lung disorder with PEMBROLIZUMAB
0.6%
of all PEMBROLIZUMAB reports
105
Deaths
290
Hospitalizations
How Dangerous Is Lung disorder From PEMBROLIZUMAB?
Of the 461 reports, 105 (22.8%) resulted in death, 290 (62.9%) required hospitalization, and 60 (13.0%) were considered life-threatening.
Is Lung disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 461 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Lung disorder?
METHOTREXATE (3,460)
ADALIMUMAB (3,185)
RITUXIMAB (2,525)
PREDNISONE (2,506)
ETANERCEPT (2,295)
TOCILIZUMAB (1,899)
ABATACEPT (1,863)
LEFLUNOMIDE (1,811)
TOFACITINIB (1,769)
INFLIXIMAB (1,691)
Which PEMBROLIZUMAB Alternatives Have Lower Lung disorder Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G